Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Steyn

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Journal of Medicinal Chemistry|June 18, 2024
Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M<sub>4</sub> Muscarinic Acetylcholine ReceptorChristopher R Butler, Michael Popiolek, Laura A McAllister, et al.
Scientific Data|May 19, 2026
Multimodal ultra-high-field MRI, clinical, cognitive, and genetic profiles across the ALS-FTD spectrumThomas B Shaw, Aiman Al Najjar, Markus Barth, et al.
British Journal of Pharmacology|November 16, 2021
Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1<sup>G93A</sup> miceSilvia Scaricamazza, Illari Salvatori, Susanna Amadio, et al.
Acta Neuropathologica Communications|April 26, 2022
Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron DiseaseQiao Ding, Kaamini Kesavan, Kah Meng Lee, et al.
Journal of Medicinal Chemistry|May 15, 2009
Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitorsAllen J Duplantier, Stacey L Becker, Michael J Bohanon, et al.
Genome Medicine|October 16, 2025
Epigenetic profiles of tissue informative CpGs inform ALS disease status and progressionChrista Caggiano, Marco Morselli, Xiaoyu Qian, et al.
Nature Communications|May 29, 2024
Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitisHaressh Sajiir, Sahar Keshvari, Kuan Yau Wong, et al.
Medchemcomm|August 16, 2018
Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacyMartin Pettersson, Douglas S Johnson, Danica A Rankic, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2015
Design and optimization of selective azaindole amide M1 positive allosteric modulatorsJennifer E Davoren, Steven V O'Neil, Dennis P Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2012
Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptorDaniel W Kung, Steven B Coffey, Ryan M Jones, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Journal of Medicinal Chemistry|June 18, 2024
Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M<sub>4</sub> Muscarinic Acetylcholine ReceptorChristopher R Butler, Michael Popiolek, Laura A McAllister, et al.
Scientific Data|May 19, 2026
Multimodal ultra-high-field MRI, clinical, cognitive, and genetic profiles across the ALS-FTD spectrumThomas B Shaw, Aiman Al Najjar, Markus Barth, et al.
British Journal of Pharmacology|November 16, 2021
Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1<sup>G93A</sup> miceSilvia Scaricamazza, Illari Salvatori, Susanna Amadio, et al.
Acta Neuropathologica Communications|April 26, 2022
Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron DiseaseQiao Ding, Kaamini Kesavan, Kah Meng Lee, et al.
Journal of Medicinal Chemistry|May 15, 2009
Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitorsAllen J Duplantier, Stacey L Becker, Michael J Bohanon, et al.
Genome Medicine|October 16, 2025
Epigenetic profiles of tissue informative CpGs inform ALS disease status and progressionChrista Caggiano, Marco Morselli, Xiaoyu Qian, et al.
Nature Communications|May 29, 2024
Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitisHaressh Sajiir, Sahar Keshvari, Kuan Yau Wong, et al.
Medchemcomm|August 16, 2018
Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacyMartin Pettersson, Douglas S Johnson, Danica A Rankic, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2015
Design and optimization of selective azaindole amide M1 positive allosteric modulatorsJennifer E Davoren, Steven V O'Neil, Dennis P Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2012
Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptorDaniel W Kung, Steven B Coffey, Ryan M Jones, et al.
Pageof 17